Neurogene Inc — Quarterly Cash Flow (NASDAQ:NGNE) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 164.12 M335.73 M315.3 M297.32 M287.83 M Total liabilities 26.71 M25.36 M23.51 M24.06 M22.29 M Total equity 137.41 M310.38 M291.8 M273.25 M265.54 M Total liabilities & shareholders' equities 164.12 M335.73 M315.3 M297.32 M287.83 M Total debt ————— Net debt —————

뉴스

Netflix, Dell among market cap stock movers on Friday

Why Is Neurogene Stock Skyrocketing Friday? - Neurogene (NASDAQ:NGNE)

뉴로진, FDA 혁신 치료제 지정에 30% 급등

Neurogene stock surges 30% on FDA breakthrough therapy status

FDA grants breakthrough therapy status to Neurogene’s Rett drug

스티펠, 뉴로진(Neurogene) 주식에 ’매수’ 등급 재확인

Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin

Neurogene doses multiple patients in Rett syndrome gene therapy trial

테이샤 유전자 치료제, Citizens "시장 수익률 상회" 등급 재확인

Citizens reiterates Market Outperform rating on Taysha Gene Therapies stock

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Neurogene: From Speculation To Execution With NGN-401 (NASDAQ:NGNE)